MD, Associate Professor (MER Pd) in Infectious Diseases at Lausanne University Hospital (CHUV), with over 15 years of recognized expertise in Clostridioides difficile infection (CDI), fecal microbiota transplantation (FMT), and microbiota-based therapeutics. Since 2019, Founder and Head of the Fecal Microbiota Transplantation (FMT) Center at CHUV, Lausanne — currently the only Swiss center accredited for FMT production. Responsible for the full implementation of the center, including infrastructure development, clinical workflows, donor and patient selection, long-term follow-up, pharmacovigilance, and national registry activities. Key areas of expertise include: • Clinical management of recurrent and severe CDI • Fecal microbiota transplantation (FMT): clinical practice, production, quality standards, and regulatory oversight • Live biotherapeutic products (LBPs) for CDI prevention • Clinical trials methodology in CDI and microbiota-based interventions • Donor screening, safety monitoring, and benefit–risk assessment • Regulatory and reimbursement pathways for microbiota-based therapies
Lausanne University Hospital (CHUV)
Lausanne, Vaud, Switzerland
Infectious disease